StockData
Skinvisible, Inc. logo

Skinvisible, Inc. (SKVI) stock

SKVIOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 0/30
$0.16+0.00 (+0.06%)

Close on Oct 19, 2026Market cap $843.54KP/E –Yield –

Skinvisible operating margin

Operating margin is operating income as a percentage of revenue.

Skinvisible's operating margin for the twelve months ending Jun 30, 2026 was -2294.9%. For fiscal 2025 it was -2481.6%, against -2947.9% the year before. The highest annual figure on record is 28.3% in fiscal 2021.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-2481.6%+466.4
FY2024Dec 31, 2024-2947.9%−496.1
FY2023Dec 31, 2023-2451.9%−2366.5
FY2022Dec 31, 2022-85.4%−113.7
FY2021Dec 31, 202128.3%+194.5
FY2020Dec 31, 2020-166.2%+1117.0
FY2019Dec 31, 2019-1283.2%−420.9
FY2018Dec 31, 2018-862.2%−804.3
FY2017Dec 31, 2017-57.9%+715.1
FY2016Dec 31, 2016-773.0%−154.2
FY2015Dec 31, 2015-618.7%+1504.7
FY2014Dec 31, 2014-2123.4%−984.6
FY2013Dec 31, 2013-1138.8%−649.0
FY2012Dec 31, 2012-489.8%+191.8
FY2011Dec 31, 2011-681.6%−332.5
FY2010Dec 31, 2010-349.2%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-2256.3%+468.4
Q1 FY2026Mar 31, 2026-2518.8%+278.3
Q4 FY2025Dec 31, 2025-2283.4%+1691.5
Q3 FY2025Sep 30, 2025-2121.1%+378.2
Q2 FY2025Jun 30, 2025-2724.7%+129.1
Q1 FY2025Mar 31, 2025-2797.0%−333.4
Q4 FY2024Dec 31, 2024-3974.9%−1244.1
Q3 FY2024Sep 30, 2024-2499.4%−237.2
Q2 FY2024Jun 30, 2024-2853.9%−597.4
Q1 FY2024Mar 31, 2024-2463.7%+94.4
Q4 FY2023Dec 31, 2023-2730.8%−376.4
Q3 FY2023Sep 30, 2023-2262.2%−897.2
Q2 FY2023Jun 30, 2023-2256.5%−2314.8
Q1 FY2023Mar 31, 2023-2558.1%−2551.0
Q4 FY2022Dec 31, 2022-2354.3%−2409.9
Q3 FY2022Sep 30, 2022-1365.0%−442.9
Q4 FY2021Dec 31, 202158.3%+52.5
Q3 FY2021Sep 30, 2021-7.0%+2828.8
Q2 FY2021Jun 30, 202155.6%+197.4
Q1 FY2021Mar 31, 2021-922.1%−112.3
Q4 FY2020Dec 31, 20205.9%+1094.8
Q3 FY2020Sep 30, 2020-2835.8%−1623.5
Q2 FY2020Jun 30, 2020-141.8%+962.2
Q1 FY2020Mar 31, 2020-809.8%+936.2
Q4 FY2019Dec 31, 2019-1088.9%+113.8
Q3 FY2019Sep 30, 2019-1212.3%−469.9
Q2 FY2019Jun 30, 2019-1104.0%−514.8
Q1 FY2019Mar 31, 2019-1746.0%−629.3
Q4 FY2018Dec 31, 2018-1202.8%−1250.6
Q3 FY2018Sep 30, 2018-742.4%−511.8
Q2 FY2018Jun 30, 2018-589.3%+162.2
Q1 FY2018Mar 31, 2018-1116.7%+115.9
Q4 FY2017Dec 31, 201747.8%+645.2
Q3 FY2017Sep 30, 2017-230.6%+969.7
Q2 FY2017Jun 30, 2017-751.5%−298.2
Q1 FY2017Mar 31, 2017-1232.6%–
Q4 FY2016Dec 31, 2016-597.4%–
Q3 FY2016Sep 30, 2016-1200.3%–
Q2 FY2016Jun 30, 2016-453.3%–

More Skinvisible figures

See a number that looks wrong?